Ascendis Health Limited, headquartered in South Africa (ZA), is a prominent player in the healthcare industry, specialising in the development and commercialisation of innovative health products. Founded in 2008, the company has established a strong presence across various operational regions, focusing on pharmaceuticals, consumer health, and medical devices. With a diverse portfolio that includes prescription medications, over-the-counter products, and nutritional supplements, Ascendis Health distinguishes itself through its commitment to quality and innovation. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position. Recognised for its dedication to improving health outcomes, Ascendis Health continues to make strides in enhancing the well-being of communities both locally and internationally.
How does Ascendis Health Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ascendis Health Limited's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ascendis Health Limited, headquartered in South Africa (ZA), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, Ascendis Health Limited's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to climate action. The company does not inherit emissions data from a parent organization, indicating that its climate impact and commitments are independently assessed. In the context of the pharmaceutical and health sector, companies are increasingly expected to adopt robust climate strategies and set measurable targets to reduce their carbon footprint. However, without specific data or commitments, it is challenging to evaluate Ascendis Health Limited's position in this regard.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ascendis Health Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
